The experience of pain in real-time during medication abortion
- 11 March 2022
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 110, 71-75
Abstract
No abstract availableKeywords
Funding Information
- Merck
- SFP Research Fund (SFPRF15-12)
This publication has 20 references indexed in Scilit:
- Pain during medical abortion, the impact of the regimen: A neglected issue? A reviewThe European Journal of Contraception & Reproductive Health Care, 2014
- Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestationActa Obstetricia et Gynecologica Scandinavica, 2014
- Prophylactic Compared With Therapeutic Ibuprofen Analgesia in First-Trimester Medical AbortionObstetrics & Gynecology, 2013
- Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled studyFertility and Sterility, 2009
- Two Distinct Oral Routes of Misoprostol in Mifepristone Medical AbortionObstetrics & Gynecology, 2008
- Predictors of acceptability of medication abortionContraception, 2007
- Treatment of pain during medical abortionContraception, 2006
- A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestationBJOG: An International Journal of Obstetrics & Gynaecology, 2005
- Acceptability and Feasibility of Early Pregnancy Termination by Mifepristone-Misoprostol: Results of a Large Multicenter Trial in the United StatesArchives of Family Medicine, 1998
- Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin MisoprostolNew England Journal of Medicine, 1993